VOYA Investment Management’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5M Buy
1,103,030
+927,561
+529% +$22.9M 0.03% 394
2026
Q1
$3.67M Buy
175,469
+127,658
+267% +$1.78M ﹤0.01% 955
2025
Q4
$424K Buy
47,811
+34,346
+255% +$296K ﹤0.01% 1824
2025
Q3
$113K Sell
13,465
-7,830
-37% -$53K ﹤0.01% 2279
2025
Q2
$109K Buy
21,295
+6,897
+48% +$17.1K ﹤0.01% 2469
2025
Q1
$19.7K Sell
14,398
-751
-5% -$1.84K ﹤0.01% 2622
2024
Q4
$46.8K Sell
15,149
-1,162
-7% -$5.39K ﹤0.01% 2694
2024
Q3
$126K Sell
16,311
-138
-0.8% -$1.32K ﹤0.01% 2606
2024
Q2
$141K Buy
16,449
+1,721
+12% +$13.3K ﹤0.01% 2582
2024
Q1
$117K Sell
14,728
-3,721
-20% -$39.9K ﹤0.01% 2598
2023
Q4
$183K Buy
18,449
+403
+2% +$3.5K ﹤0.01% 2601
2023
Q3
$203K Sell
18,046
-430
-2% -$2.62K ﹤0.01% 2536
2023
Q2
$61.3K Buy
18,476
+1,105
+6% +$3.98K ﹤0.01% 2883
2023
Q1
$68.6K Hold
17,371
– – ﹤0.01% 2756
2022
Q4
$126K Hold
17,371
– – ﹤0.01% 2704
2022
Q3
$62.9K Hold
17,371
– – ﹤0.01% 2870
2022
Q2
$79K Buy
+17,371
New +$105K ﹤0.01% 2677

Other funds holding TNGX

VOYA Investment Management's TNGX Position: Q2 2026 in Review

VOYA Investment Management increased its Tango Therapeutics (TNGX) stake by 529% in Q2 2026, buying an estimated $22.9M and bringing the position to 1,103,030 shares worth $34.5M. The position accounts for 0.03% of the portfolio, ranked #394.

VOYA Investment Management first reported a position in TNGX in Q2 2022 and has held it in 17 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • VOYA Investment Management held 1,103,030 shares of Tango Therapeutics worth $34.5M as of Q2 2026.
  • VOYA Investment Management bought 927,561 Tango Therapeutics shares in Q2 2026, an estimated $22.9M.
  • Tango Therapeutics made up 0.03% of VOYA Investment Management's portfolio in Q2 2026, its #394 holding.
  • VOYA Investment Management first reported a position in Tango Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.